Vimian Group acquires a leading online platform for veterinary pharmaceuticals

Vimian Group acquires a leading online platform for veterinary pharmaceuticals

STOCKHOLM, SWEDEN / ACCESSWIRE / August 2, 2022 / Vimian Group (STO:VIMIAN)

Vimian Group has acquired Heiland GmbH (“”), a leading online ordering platform offering veterinary pharmaceuticals and other veterinary products to veterinary clinics throughout Germany. The acquisition marks a key milestone in Vimian Group’s strategy to digitize its global veterinary clinic service offering. has an annual revenue of around 1.5 million euros.

Vimian VetFamily’s veterinary services segment has acquired Heiland GmbH (“”). Founded in 2018, is a family business that has quickly grown into the leading online one-stop shop for veterinary pharmaceuticals in Germany with over 1,700 monthly active users and more than 40,000 products from over 100 manufacturers. had a growth rate of 26 percent in 2021.

“By acquiring, we gain access to a leading technology platform and purchasing portal for veterinary clinics that we can leverage across all of our geographies to drive sales and enhance our offerings to clinics and strategic partners.” Veterinarians benefit from increased efficiency and convenience when processing all orders in one interface. is growing rapidly with high margins and enjoys an attractive market position with proprietary technology, a loyal customer base and a strong brand.” says Alireza Tajbakhsh, CEO of Vimian VetFamily’s Veterinary Services segment.

The acquisition will have a minor impact on Vimian Group’s earnings per share in the current financial year. was consolidated into Vimian Group’s Veterinary Services segment on August 1, 2022.

For further information, please contact:

Maria Dalloff Tulberg
Head of IR, Communications and Sustainability
[email protected]
+46 736 26 88 86

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact by improving animal health. Together, we put science, technology and the needs of our customers at the center of everything we do to provide effective solutions to veterinarians, laboratories and pet parents around the world. We bring together innovative and entrepreneurial animal health businesses to create a uniquely diversified offering of products and services of the highest standard. Our group covers four main and fast-growing areas of animal health: specialty pharmacy, diagnostics, veterinary services and medical technology. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are passionate about supporting leadership in our existing businesses as well as welcoming new partners to the Vimian family – together helping us achieve even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 700 people and have a total annual turnover of approximately €170 million. FNCA Sweden AB has been appointed as the company’s certified advisor, [email protected], +46 (0) 8-528 00 399. For more information, please visit:

Attached files

Vimian Group acquires a leading online platform for veterinary pharmaceuticals

SOURCE: Vimian Group

Check out the source version of

Leave a Comment

Your email address will not be published.